<DOC>
	<DOCNO>NCT02978508</DOCNO>
	<brief_summary>This multi-center , double-blind , randomize , two arm parallel design study . This study comprise two phase : screening treatment . The screening period 5 day , follow treatment phase 28±4 day . During treatment phase subject randomize receive either test reference treatment double-blind manner outpatient setting . Randomization subject 1:1 ratio test reference drug arm stratify site . Screening begin visit 1 , eligibility determine prohibited treatment discontinue . Randomization occur follow confirmation eligibility criterion visit 2 ( baseline , Day 1 ) i.e . initiation treatment phase . The treatment phase 28±4 day duration wherein subject receive treatment investigational product ( either test reference ) Day 1 Baseline ( visit 2 ) . Safety tolerability assessment perform Day 7 ( visit 3 ) . Efficacy , safety tolerability assess Day 14 ( visit 4 ) follow End study visit Day 28 ( visit 5 ) . If positive identification scabies confirm Day 14 ( visit 4 ) , subject retreat second application investigational product .</brief_summary>
	<brief_title>Bio-equivalence Study Comparing Permethrin Cream , 5 % With Elimite Patients With Active Scabies .</brief_title>
	<detailed_description />
	<mesh_term>Scabies</mesh_term>
	<mesh_term>Permethrin</mesh_term>
	<criteria>1 . Male nonpregnant , nonlactating female subject least 12 year age old . 2 . Subject must positive identification mite , egg , mite fecal matter microscopic examination skin scraping . 3 . Subjects must least two three follow : ) excoriation inflammatory papule typical distribution pattern localization ( webbed space finger , flexor surface wrist , elbow , axilla , belt line , foot , skin surface external genitalia , areola ) ; b ) presence burrow ; c ) family contact moderate severe itching increase night . 4 . Subjects must willing make every effort immediately disinfect clothes , towel , linens potentially infect household item upon diagnosis infestation prevent reinfestation . 5 . All household member prolong physical contact subject must willing attend Baseline visit receive treatment standard care deem necessary Investigator order prevent reinfestation subject enrol . 6 . Subject representative must read sign Institutional Review Board/Independent Ethics Committee ( IRB/IEC ) approve Informed Consent Form ( ICF ) ; minor subject ( 18 year young state ) parent legal guardian sign ICF child require sign Assent Form write way understandable child . 7 . Subject must able apply study product self . If subject child , parent/guardian apply study product him/her . 1 . Females pregnant show urine pregnancy test Baseline visit , prior randomization , lactating , childbearing potential ( purpose study female childbearing potential consider surgically sterile postmenopausal least 1 year ) use agree use acceptable form contraception ( oral /implant /injectable /transdermal contraceptive , intrauterine device ( IUD ) , condom , diaphragm , abstinence ) study , intend become pregnant study ; contraceptive method must also consistent throughout study . 2 . Treatment scabies &lt; 4 week prior enrollment , include permethrin , benzyl alcohol , lindane , crotamiton , malathion , ivermectin . 3 . Use prohibit medication : Topical oral scabicidal/antiparasitic treatment include : permethrin , benzyl alcohol , benzyl benzoate , lindane , crotamiton , malathion , ivermectin , precipitate sulfur , albendazole , keratolytic cream , tea tree oil , oil leaf Lippia multiflora Moldenke within 28 day visit 2 . Systemic corticosteroid ( include inhale steroid ) take within 14 day visit 2 . Topical corticosteroid include hydrocortisone take within 24 hour visit 2 . Topical antipruritic , include antihistamine within 24 hour study visit . Oral antihistamine include diphenhydramine ( Benadryl ) take within 24 hour study visit . Topical antibiotic include mupirocin take within 24 hour study visit . 4 . Patients immunosuppressive disorder require therapy , severe systemic disease , history HIV infection and/or seizure . 5 . Patients crusted/Norwegian scabies . 6 . Presence underlie skin disease would obscure evaluation papule burrow associated scabies infection determine Investigator . 7 . Presence severe cutaneous bacterial fungal infection require therapy ( include systemic topical antibiotic ) determine Investigator . 8 . Sensitivity allergy Permethrin Cream component , synthetic pyrethroids , pyrethrin , chrysanthemum ragweed . 9 . A recent ( less 1 year ) history alcoholism , drug abuse , problem would likely make subject unreliable study . 10 . Participation another investigational study use investigational product within 30 day prior Baseline visit . 11 . Participation family member , another member household ( include regular bedmates ) current study . 12 . Total number bedmates family member prolong physical contact great 6 ( include study subject ) . 13 . Any employee clinic , investigator , family member study staff . 14 . Patients opinion Investigator would noncompliant requirement study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>